RAYMOND W COHEN
CIK 1258288 · Chief Executive Officer · last filed 2026-06-18
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$2.94M
Companies
7
Total Filings
77
Lifetime Open-Market Net
-$38.12M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| RXST | Director | 66,532 | $7.00 | $466.1K | $0 | 2 | 2026-06-18 |
| KMTS | Director | 50,903 | $28.07 | $1.43M | $488.8K | 3 | 2026-03-30 |
| NSPR | Director | 92,417 | $0.84 | $77.2K | $0 | 1 | 2026-01-16 |
| Axonics, Inc. (AXNX) Delisted | Chief Executive Officer | 692,151 | $70.98 | $49.13M | -$36.75M | 27 | 2024-11-15 |
| BLFS | Director | 27,763 | $34.79 | $965.9K | -$1.69M | 21 | 2021-07-14 |
| SPECTRUM PHARMACEUTICALS INC (SPPI) Delisted | Director | 53,850 | $1.03 | $55.5K | -$169.9K | 11 | 2019-06-21 |
| Cardiac Science CORP (CSCX) Delisted | Director | 13,825 | — | — | $0 | 4 | 2009-05-27 |
Recent Filings · Page 2 of 8
77 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2023-01-18 | Axonics, Inc. (AXNX) Delisted | Sell (S) | −40,736 | -$2.69M | EDGAR |
| 2022-08-10 | Axonics, Inc. (AXNX) Delisted | Sell (S) | −44,000 | -$3.10M | EDGAR |
| 2022-03-31 | Axonics, Inc. (AXNX) Delisted | Sell (S) | −50,000 | -$3.00M | EDGAR |
| 2022-03-16 | Axonics, Inc. (AXNX) Delisted | Sell (S) | −50,000 | -$2.64M | EDGAR |
| 2022-02-03 | Axonics, Inc. (AXNX) Delisted | Mixed | +105,028 | -$1.69M | EDGAR |
| 2021-09-13 | Axonics, Inc. (AXNX) Delisted | Sell (S) | −50,000 | -$3.86M | EDGAR |
| 2021-07-14 | BLFS | Grant (A) | +5,000 | $0 | EDGAR |
| 2021-06-10 | Axonics, Inc. (AXNX) Delisted | Sell (S) | −33,333 | -$2.00M | EDGAR |
| 2021-05-20 | Axonics, Inc. (AXNX) Delisted | Sell (S) | −32,833 | -$1.81M | EDGAR |
| 2021-05-12 | Axonics, Inc. (AXNX) Delisted | Sell (S) | −33,833 | -$1.82M | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.